{"url":"https://lda.senate.gov/api/v1/filings/53291d57-69e2-45f3-9dcc-83e283f5e779/","filing_uuid":"53291d57-69e2-45f3-9dcc-83e283f5e779","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2022,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/53291d57-69e2-45f3-9dcc-83e283f5e779/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2022-07-19T09:52:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.senate.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":213480,"url":"https://lda.senate.gov/api/v1/clients/213480/","client_id":265,"name":"GOODCELL","general_description":"Healthcare, science, and technology company in the blood, gene, and stem cell space","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Support a determination that storing blood cells is Flexible Saving Account (FSA), Health Savings Account (HSA) and Health Reimbursement Arrangement (HRA) eligible under the Internal Revenue Code (IRC) Section 213(d) to help diagnosis, cure, mitigate, treat, or prevent a disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Support a determination that storing blood cells is Flexible Saving Account (FSA), Health Savings Account (HSA) and Health Reimbursement Arrangement (HRA) eligible under the Internal Revenue Code (IRC) Section 213(d) to help diagnosis, cure, mitigate, treat, or prevent a disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}